phenoxybenzamine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ziegler, CG | 1 |
| Riediger, C | 1 |
| Gruber, M | 1 |
| Kunath, C | 1 |
| Ullrich, M | 1 |
| Pietzsch, J | 1 |
| Nölting, S | 1 |
| Siepmann, T | 1 |
| Bornstein, SR | 1 |
| Remde, H | 1 |
| Constantinescu, G | 1 |
1 other study available for phenoxybenzamine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Case report: Incidentally discovered case of pheochromocytoma as a cause of long COVID-19 syndrome.
Topics: Adrenal Gland Neoplasms; Adult; Blood Pressure Monitoring, Ambulatory; COVID-19; Dizziness; Humans; | 2022 |